@coachdjvanillaface's testosterone stability claims checked
Quick answer
Testosterone replacement therapy can trigger or worsen acne through increased DHT activity at the sebaceous gland and, to a lesser extent, hormonal flux during dose peaks. Injection frequency adjustments to reduce peak-to-trough testosterone variability are a clinically recognized strategy, and persistent cases warrant evaluation by a dermatologist rather than self-managed off-label peptide use. Compounds like melanotan II are not FDA-approved, carry documented adverse effects, and should not be used without physician oversight.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @coachdjvanillaface actually say?
The creator laid out a tiered approach to managing acne on testosterone replacement therapy. The core argument: early acne is caused by hormone fluctuations, persistent acne ties to DHT or estradiol shifts, and the fix is "serum stability" through more frequent injections. Practical steps included hygiene habits, benzoyl peroxide cream, a GHK-Cu serum, zinc, omega fatty acids, and what the creator called "melonotane" as an off-label favorite. Antibiotics and low-dose isotretinoin were mentioned as last resorts.
The video is structured clearly and avoids some of the worst TRT-influencer tropes. But it also recommends a peptide by name, links to a personal Amazon storefront, and uses a term ("melonotane") that doesn't match any established pharmacological compound, which raises immediate questions.
Does the science back this up?
Mostly yes on the hormonal mechanisms, with some meaningful gaps. The DHT and sebaceous gland connection is well-established. Estradiol's role in acne is less settled than the creator implies.
DHT stimulates sebaceous gland activity and is a recognized driver of androgen-induced acne. This is documented in Zouboulis et al. (2014, Clinical and Experimental Dermatology), which confirmed that 5-alpha reductase activity in sebocytes directly promotes sebum overproduction. The "injection frequency" argument also has a real pharmacokinetic basis: longer injection intervals produce higher peak testosterone concentrations, which correlate with greater DHT conversion. A 2021 analysis by Ramasamy et al. in the Journal of Urology noted that more frequent dosing reduces peak-to-trough variability.
The estradiol-acne link is murkier. Estrogen actually has some anti-inflammatory and sebosuppressive properties in certain contexts. Framing high estradiol as a straightforward acne driver oversimplifies the literature. Zinc supplementation has modest evidence behind it (Dreno et al., 2018, Journal of the European Academy of Dermatology), and omega-3s have anti-inflammatory data that's plausible but indirect for acne specifically.
What did they get wrong (or right)?
The creator got the foundational pharmacology largely right. The injection frequency recommendation is clinically reasonable and underused advice. The hygiene section is basic but accurate.
Where things go sideways: "melonotane" is not a recognized compound name. The creator likely means melanotan II, a synthetic melanocortin receptor agonist. Melanotan II is not approved by the FDA, has no robust clinical trial data for acne, and carries real risks including nausea, spontaneous erections, and potential melanoma promotion based on animal data (Mountjoy, 2015, European Journal of Pharmacology). Recommending it as a favorite off-label approach without flagging those risks is irresponsible.
The GHK-Cu recommendation linked to a personal Amazon storefront is a conflict of interest that goes unacknowledged. GHK-Cu (copper peptide) has some in vitro anti-inflammatory data, but evidence in humans for acne specifically is thin. Calling it inflammation-fighting without that caveat is a stretch. The creator should not be monetizing supplement recommendations inside a medical advice video without disclosing that relationship clearly.
What should you actually know?
TRT-induced acne is real, common, and manageable through legitimate means. You don't need unregulated peptides or off-label melanocortin agonists to address it.
If you're dealing with persistent acne on TRT, the evidence-supported steps are: talk to your prescriber about injection frequency adjustments, use proven topicals like benzoyl peroxide or retinoids, and if those fail, a dermatologist can prescribe isotretinoin or antibiotics with proper monitoring. Micro-dosing isotretinoin, which the creator mentions, is a legitimate practice discussed in the dermatology literature (Sardana et al., 2019, Dermatologic Therapy), but it requires physician oversight, not a TikTok protocol.
Anyone recommending melanotan II for acne without disclosing the risk profile is doing you a disservice. And any creator linking supplement recommendations to their own Amazon storefront inside a medical advice video has a financial interest you deserve to know about upfront.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @coachdjvanillaface's testosterone stability claims checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
SCENESSE (afamelanotide implant) FDA Prescribing Information
Afamelanotide (an alpha-MSH analog) is the only FDA-approved melanocortin peptide of this class, and only to increase pain-free light exposure in erythropoietic protoporphyria, not for cosmetic tanning.
FDA
Afamelanotide for Erythropoietic Protoporphyria
Randomized placebo-controlled trials (NEJM) behind the afamelanotide approval; this is the legitimate human melanocortin evidence, distinct from unapproved tanning peptides.
PubMed
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@coachdjvanillaface's testosterone stability claims checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone replacement therapy can trigger or worsen acne through increased DHT activity at the sebaceous gland and, to a lesser extent, hormonal flux during dose peaks.
FormBlends verdict
Testosterone replacement therapy can trigger or worsen acne through increased DHT activity at the sebaceous gland and, to a lesser extent, hormonal flux during dose peaks. Injection frequency adjustments to reduce peak-to-trough testosterone variability are a clinically recognized strategy, and persistent cases warrant evaluation by a dermatologist rather than self-managed off-label peptide use. Compounds like melanotan II are not FDA-approved, carry documented adverse effects, and should not be used without physician oversight.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone replacement therapy can trigger or worsen acne through increased DHT activity at the sebaceous gland and, to a lesser extent, hormonal flux during dose peaks. Injection frequency adjustments to reduce peak-to-trough testosterone variability are a clinically recognized strategy, and persistent cases warrant evaluation by a dermatologist rather than self-managed off-label peptide use. Compounds like melanotan II are not FDA-approved, carry documented adverse effects, and should not be used without physician oversight.
- DHT, not estradiol, is the better-established driver of androgen-induced acne; the estradiol-acne relationship is more complex than the video implies.
- Increasing injection frequency to flatten testosterone peaks is pharmacokinetically sound and supported by clinical literature on TRT dosing variability.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- DHT, not estradiol, is the better-established driver of androgen-induced acne; the estradiol-acne relationship is more complex than the video implies.
- Increasing injection frequency to flatten testosterone peaks is pharmacokinetically sound and supported by clinical literature on TRT dosing variability.
- Melanotan II, the likely compound referenced as 'melonotane,' is unapproved by the FDA, lacks human acne trial data, and carries risks including potential melanoma promotion based on animal studies.
- Zinc supplementation for acne has modest clinical support; a 2018 Dreno et al. review in the Journal of the European Academy of Dermatology found benefit primarily for inflammatory lesions.
- Low-dose isotretinoin for persistent acne is a legitimate dermatology approach, but requires physician monitoring for liver enzymes, lipids, and psychiatric side effects, not casual self-administration.
- GHK-Cu copper peptides have in vitro anti-inflammatory data but no human clinical trial evidence for TRT-related acne specifically.
- Any creator linking supplement recommendations to a personal Amazon storefront inside a medical advice video has an undisclosed financial interest that should factor into how you weigh their suggestions.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dj Madson · TikTok creator
31.6K views on this video
Serum stability above all! #acne #trt #testosterone #skincare #bodybuilding #gains
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dj Madson, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.